• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • Devex Impact
    • Private sector development

    Building the business case for health sector strengthening

    London-based pharmaceutical company GlaxoSmithKline PLC announced a commitment Friday to train more than 9,000 health workers in Ghana, Kenya and Nigeria in partnership with NGOs and in-country governments. What does it take to build the case for private sector investment in health systems?

    By Jeff Tyson // 22 May 2015
    As the Ebola virus in West Africa wanes, multilateral and bilateral donors along with NGOs and country governments are making a concerted push to strengthen health systems across the developing world to protect against future health crises. But at what point does health systems strengthening become a good business investment for the private sector? The U.K.-based pharmaceutical company GlaxoSmithKline PLC announced today that it will invest more than $9 million over the course of three years to support the training of more than 9,000 health workers in Ghana, Kenya and Nigeria. The initiative, in partnership with nongovernmental organizations Amref Health Africa, the One Million Community Health Workers Campaign and Save the Children, is designed to train health care workers to manage noncommunicable diseases, treat mothers, children, and newborns, and build an evidence base that makes the case for both public and private investments in the health sector. So why does such an investment make business sense? By investing in health infrastructure in developing economies, GSK can help to create a market and a demand for its products, said Ramil Burden, vice president for Africa and developing countries at the organization. “You cannot just simply complain as a company that the infrastructure doesn’t exist and therefore there is no market. You have a role actually in creating that market,” he said. GSK has prioritized investing in health systems since at least 2009, when it began reinvesting 20 percent of the profits it generated in the least developed countries back into the health systems of those countries. In 2013 the company partnered with Save the Children to ensure that vaccines were available to children in poverty. And within the last year, GSK opened a lab for research into noncommunicable diseases and engaged with universities throughout Africa to support science and health training programs. Burden explained that by introducing better health care workers in communities and educating the public about medical treatment options, families will begin to seek out care and treatments, including pharmaceuticals. “By working with community health care workers, we are creating an ecosystem that improves health outcomes and also increases demand in the system,” Burden said. For pharmaceutical companies such as GSK, the business case for investing in health infrastructure may seem more robust and clear cut than for other companies that don’t have direct links to the health sector. But Burden thinks other companies also have a lot to gain from healthier communities that could jumpstart markets in other sectors. “I thought the [fast moving consumer goods] companies, the [telecommunication] companies … would come in behind this. But actually … they haven’t,” Burden said, adding that it can be hard to demonstrate the long-term benefit of the investment. Through GSK’s latest investment in Ghana, the pharmaceutical company in partnership with the One Million Community Health Workers Campaign and the Ghanaian government intend to build an evidence base demonstrating the effectiveness of the different types of training healthcare workers receive, the health outcomes achieved and — Burden hopes — the value for money. “This is really about showing that this is a good investment,” Burden said. If they can demonstrate that, Burden and his team hope to create a “catalytic effect” in which the Ghanaian government enacts a national community health care worker program, and other private sector actors see a reason to invest in health systems. What are some other ways to strengthen the case for investment in health systems? Let us know by leaving a comment below. Join Devex to network with peers, discover talent and forge new partnerships in international development — it’s free. Then sign up for the Devex Impact newsletter to receive cutting-edge news and analysis at the intersection of business and development.

    As the Ebola virus in West Africa wanes, multilateral and bilateral donors along with NGOs and country governments are making a concerted push to strengthen health systems across the developing world to protect against future health crises.

    But at what point does health systems strengthening become a good business investment for the private sector?

    The U.K.-based pharmaceutical company GlaxoSmithKline PLC announced today that it will invest more than $9 million over the course of three years to support the training of more than 9,000 health workers in Ghana, Kenya and Nigeria.

    This article is free to read - just register or sign in

    Access news, newsletters, events and more.

    Join usSign in
    • Global Health
    • Ghana
    • Kenya
    • Nigeria
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Jeff Tyson

      Jeff Tyson@jtyson21

      Jeff is a former global development reporter for Devex. Based in Washington, D.C., he covers multilateral affairs, U.S. aid, and international development trends. He has worked with human rights organizations in both Senegal and the U.S., and prior to joining Devex worked as a production assistant at National Public Radio. He holds a master's degree in journalism from Columbia University and a bachelor’s degree in international relations and French from the University of Rochester.

    Search for articles

    Related Stories

    Sponsored by AmgenStrengthening health systems by measuring what really matters

    Strengthening health systems by measuring what really matters

    Global HealthOpinion: Financing health for all requires bold moves away from aid

    Opinion: Financing health for all requires bold moves away from aid

    78th World Health AssemblyA new model for funding global health takes shape

    A new model for funding global health takes shape

    Accelerating Action: Sponsored by World Child CancerOpinion: UHC must start somewhere — why not childhood cancer?

    Opinion: UHC must start somewhere — why not childhood cancer?

    Most Read

    • 1
      Opinion: AI-powered technologies can transform access to health care
    • 2
      Exclusive: A first look at the Trump administration's UNGA priorities
    • 3
      WHO anticipates losing some 600 staff in Geneva
    • 4
      Opinion: Resilient Futures — a world where young people can thrive
    • 5
      AIIB turns 10: Is there trouble ahead for the China-backed bank?
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement